Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umit Topaloglu

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
JCO Clinical Cancer Informatics|August 7, 2020
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data PoolingStacy Thomas, Tara Lichtenberg, Kristen Dang, et al.
Frontiers in Oncology|November 29, 2023
Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastasesMohammed Abdulhaleem, John C Hunting, Yuezhu Wang, et al.
Cancers|November 27, 2021
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell CarcinomaKimberly M Burcher, Jeffrey W Lantz, Elena Gavrila, et al.
Molecular Oncology|October 27, 2020
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysisLiang Liu, Tamjeed Ahmed, William J Petty, et al.
Cancer Medicine|April 30, 2019
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seqQianqian Song, Gregory A Hawkins, Leonard Wudel, et al.
JAMA Internal Medicine|December 28, 2021
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the USJing Sun, Qulu Zheng, Vithal Madhira, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
Patterns (New York, N.Y.)|November 24, 2022
A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI imagesQing Lyu, Sanjeev V Namjoshi, Emory McTyre, et al.
The Lancet. Oncology|May 13, 2017
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trialAngela Alistar, Bonny B Morris, Rodwige Desnoyer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported informationHalie M Rando, Tellen D Bennett, James Brian Byrd, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
JCO Clinical Cancer Informatics|August 7, 2020
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data PoolingStacy Thomas, Tara Lichtenberg, Kristen Dang, et al.
Frontiers in Oncology|November 29, 2023
Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastasesMohammed Abdulhaleem, John C Hunting, Yuezhu Wang, et al.
Cancers|November 27, 2021
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell CarcinomaKimberly M Burcher, Jeffrey W Lantz, Elena Gavrila, et al.
Molecular Oncology|October 27, 2020
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysisLiang Liu, Tamjeed Ahmed, William J Petty, et al.
Cancer Medicine|April 30, 2019
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seqQianqian Song, Gregory A Hawkins, Leonard Wudel, et al.
JAMA Internal Medicine|December 28, 2021
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the USJing Sun, Qulu Zheng, Vithal Madhira, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
Patterns (New York, N.Y.)|November 24, 2022
A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI imagesQing Lyu, Sanjeev V Namjoshi, Emory McTyre, et al.
The Lancet. Oncology|May 13, 2017
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trialAngela Alistar, Bonny B Morris, Rodwige Desnoyer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported informationHalie M Rando, Tellen D Bennett, James Brian Byrd, et al.
Pageof 9